626216-00-0 Usage
Uses
Used in Pharmaceutical Research:
[2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-(5-METHYL-FURAN-2-YLMETHYL)-AMINE is used as a potential therapeutic agent for various medical conditions due to its unique molecular structure and potential biological activity.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, [2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-(5-METHYL-FURAN-2-YLMETHYL)-AMINE is used as a compound for designing and developing new drugs, targeting specific biological pathways and receptors.
Used in Drug Delivery Systems:
[2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-(5-METHYL-FURAN-2-YLMETHYL)-AMINE can be utilized as a component in the development of novel drug delivery systems, potentially enhancing the bioavailability and targeting of therapeutic agents.
Used in Chemical Synthesis:
[2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-(5-METHYL-FURAN-2-YLMETHYL)-AMINE can also be used as a building block or intermediate in the synthesis of more complex molecules for various applications in the chemical and pharmaceutical industries.
Used in Material Science:
The unique structure of [2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-(5-METHYL-FURAN-2-YLMETHYL)-AMINE may also find applications in material science, potentially contributing to the development of new materials with specific properties.
Check Digit Verification of cas no
The CAS Registry Mumber 626216-00-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,6,2,1 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 626216-00:
(8*6)+(7*2)+(6*6)+(5*2)+(4*1)+(3*6)+(2*0)+(1*0)=130
130 % 10 = 0
So 626216-00-0 is a valid CAS Registry Number.
626216-00-0Relevant articles and documents
PROCESS FOR PREPARING QUINUCLIDINIUM CARBAMATE DERIVATIVES
-
Page/Page column 20, (2008/06/13)
The invention relates to a new process for preparing carbamate derivatives having the structure of formula (I) by reacting, in a first step, a compound of formula (II) with a compound of formula (III) and reacting the product of this first step with an ac
NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
-
Page 25-26, (2008/06/13)
Carbamates of formula (I) or pharmaceutically acceptable salts thereof, including quaternary ammonium salts of formula (II) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.
